End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-20 EDT
|
5-day change
|
1st Jan Change
|
2.36
CNY
|
-1.67%
|
|
-3.28%
|
-22.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,416
|
4,458
|
3,301
|
6,827
|
12,861
|
10,335
|
Enterprise Value (EV)
1 |
9,512
|
6,336
|
4,909
|
6,692
|
13,588
|
11,761
|
P/E ratio
|
-4.53
x
|
-1.8
x
|
-63.2
x
|
-18.4
x
|
82.6
x
|
333
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.67
x
|
1.21
x
|
1.18
x
|
2.26
x
|
4.08
x
|
2.88
x
|
EV / Revenue
|
2.48
x
|
1.72
x
|
1.75
x
|
2.22
x
|
4.31
x
|
3.28
x
|
EV / EBITDA
|
-37.8
x
|
25.6
x
|
14.3
x
|
56.2
x
|
36.3
x
|
32.9
x
|
EV / FCF
|
22.1
x
|
3.14
x
|
64.6
x
|
26.4
x
|
-18.9
x
|
-14.7
x
|
FCF Yield
|
4.53%
|
31.9%
|
1.55%
|
3.79%
|
-5.28%
|
-6.81%
|
Price to Book
|
2.37
x
|
22.9
x
|
24.7
x
|
4.4
x
|
7.46
x
|
4.71
x
|
Nbr of stocks (in thousands)
|
1,865,236
|
1,865,236
|
1,865,236
|
1,865,236
|
3,264,164
|
3,410,759
|
Reference price
2 |
3.440
|
2.390
|
1.770
|
3.660
|
3.940
|
3.030
|
Announcement Date
|
4/29/19
|
4/29/20
|
4/28/21
|
4/28/22
|
4/13/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,838
|
3,684
|
2,806
|
3,016
|
3,153
|
3,590
|
EBITDA
1 |
-251.5
|
247.2
|
344.4
|
119.1
|
374.8
|
357.2
|
EBIT
1 |
-478.7
|
117.1
|
179.3
|
-35.57
|
229.8
|
168.5
|
Operating Margin
|
-12.47%
|
3.18%
|
6.39%
|
-1.18%
|
7.29%
|
4.69%
|
Earnings before Tax (EBT)
1 |
-1,334
|
-2,437
|
9.991
|
-362.4
|
187.5
|
10.26
|
Net income
1 |
-1,418
|
-2,520
|
-52.24
|
-371.4
|
155.6
|
30.78
|
Net margin
|
-36.94%
|
-68.38%
|
-1.86%
|
-12.32%
|
4.94%
|
0.86%
|
EPS
2 |
-0.7601
|
-1.327
|
-0.0280
|
-0.1991
|
0.0477
|
0.009100
|
Free Cash Flow
1 |
430.8
|
2,018
|
76.03
|
253.4
|
-717.3
|
-800.8
|
FCF margin
|
11.22%
|
54.78%
|
2.71%
|
8.4%
|
-22.75%
|
-22.3%
|
FCF Conversion (EBITDA)
|
-
|
816.57%
|
22.08%
|
212.78%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/29/19
|
4/29/20
|
4/28/21
|
4/28/22
|
4/13/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,096
|
1,878
|
1,608
|
-
|
728
|
1,427
|
Net Cash position
1 |
-
|
-
|
-
|
135
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-12.31
x
|
7.598
x
|
4.669
x
|
-
|
1.941
x
|
3.994
x
|
Free Cash Flow
1 |
431
|
2,018
|
76
|
253
|
-717
|
-801
|
ROE (net income / shareholders' equity)
|
-38.5%
|
-163%
|
-23.3%
|
-42.1%
|
9.8%
|
1.95%
|
ROA (Net income/ Total Assets)
|
-3.15%
|
1.07%
|
2.3%
|
-0.39%
|
2.33%
|
1.79%
|
Assets
1 |
45,046
|
-235,339
|
-2,269
|
96,151
|
6,683
|
1,715
|
Book Value Per Share
2 |
1.450
|
0.1000
|
0.0700
|
0.8300
|
0.5300
|
0.6400
|
Cash Flow per Share
2 |
0.1900
|
0.0700
|
0.0900
|
1.090
|
0.1700
|
0.1700
|
Capex
1 |
220
|
216
|
217
|
199
|
222
|
195
|
Capex / Sales
|
5.74%
|
5.86%
|
7.72%
|
6.59%
|
7.03%
|
5.44%
|
Announcement Date
|
4/29/19
|
4/29/20
|
4/28/21
|
4/28/22
|
4/13/23
|
4/17/24
|
|
1st Jan change
|
Capi.
|
---|
| -22.11% | 1.13B | | +18.28% | 85.14B | | -27.47% | 72.06B | | +2.75% | 27.07B | | -9.55% | 17.43B | | -1.96% | 16.98B | | +3.53% | 16.02B | | +7.93% | 13.87B | | +70.73% | 13.06B | | +72.84% | 12.79B |
Other Healthcare Facilities & Services
|